These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 2124033

  • 21. Analysis of acylcarnitine levels by tandem mass spectrometry in epileptic children receiving valproate and oxcarbazepine.
    Cansu A, Serdaroglu A, Biberoglu G, Tumer L, Hirfanoglu TL, Ezgu FS, Hasanoglu A.
    Epileptic Disord; 2011 Dec; 13(4):394-400. PubMed ID: 22258044
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetic interaction of brivaracetam on carbamazepine in adult patients with epilepsy, with and without valproate co-administration.
    Stockis A, Sargentini-Maier ML, Brodie MJ.
    Epilepsy Res; 2016 Dec; 128():163-168. PubMed ID: 27842261
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparison of add-on valproate and primidone in carbamazepine-unresponsive patients with partial epilepsy.
    Sun MZ, Deckers CL, Liu YX, Wang W.
    Seizure; 2009 Mar; 18(2):90-3. PubMed ID: 18672385
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of monotherapy with valproate and other antiepileptic drugs in the treatment of seizure disorders.
    Chadwick D.
    Am J Med; 1988 Jan 25; 84(1A):3-6. PubMed ID: 3146223
    [Abstract] [Full Text] [Related]

  • 29. Sodium valproate in the treatment of resistant epilepsy.
    Hassan MN, Laljee HC, Parsonage MJ.
    Acta Neurol Scand; 1976 Sep 25; 54(3):209-218. PubMed ID: 822682
    [Abstract] [Full Text] [Related]

  • 30. Thyroid hormone levels in children receiving carbamazepine or valproate.
    Aggarwal A, Rastogi N, Mittal H, Chillar N, Patil R.
    Pediatr Neurol; 2011 Sep 25; 45(3):159-62. PubMed ID: 21824562
    [Abstract] [Full Text] [Related]

  • 31. Weight gain with valproate or carbamazepine--a reappraisal.
    Easter D, O'Bryan-Tear CG, Verity C.
    Seizure; 1997 Apr 25; 6(2):121-5. PubMed ID: 9153724
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Sodium valproate in epilepsy treatment.
    Brown EG.
    Practitioner; 1986 Mar 25; 230(1413):204. PubMed ID: 3086857
    [No Abstract] [Full Text] [Related]

  • 36. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.
    Beydoun A, Sachdeo RC, Rosenfeld WE, Krauss GL, Sessler N, Mesenbrink P, Kramer L, D'Souza J.
    Neurology; 2000 Jun 27; 54(12):2245-51. PubMed ID: 10881247
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Plasma concentrations of sodium valproate: their clinical value.
    Turnbull DM, Rawlins MD, Weightman D, Chadwick DW.
    Ann Neurol; 1983 Jul 27; 14(1):38-42. PubMed ID: 6412620
    [Abstract] [Full Text] [Related]

  • 40. Rational use of valproate: indications and drug regimen in epilepsy.
    Loiseau P.
    Epilepsia; 1984 Jul 27; 25 Suppl 1():S65-72. PubMed ID: 6425050
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.